| 1 | 53123-88-9 | 雷帕霉素 | Sirolimus | C51H79NO13
| 原料;原料药;发酵类;中间体;抗生素;对照品;标准品;抑制剂;抗肿瘤;科研试剂 | |
| 2 | 147438-27-5 | Seco Rapamycin | Seco Rapamycin | C51H79NO13
| 科研试剂 | |
| 3 | 253431-35-5 | 28-异帕雷帕霉素 | 28-epirapamycin | C51H79NO13
| | |
| 4 | 157182-37-1 | 西罗莫司杂质2 | Rapamycin, (7R)- | C51H79NO13
| | |
| 5 | 150821-39-9 | 雷帕霉素杂质2 | Rapamycin Impurity 2 | C51H79NO13
| | |
| 6 | | RapaMycin-d3 (contains d0) Technical Grade | RapaMycin-d3 (contains d0) Technical Grade | C51H79NO13
| Chiral Reagents;Heterocycles;Inhibitors;Intermediates & Fine Chemicals;Isotope Labelled Compounds;Pharmaceuticals | |
| 7 | 56145-07-4 | 2-Amino-2-deoxygalactose tetrakis(trimethylsilyl)deriv. | 2-Amino-2-deoxygalactose tetrakis(trimethylsilyl)deriv. | C51H79NO13
| | |
| 8 | 144293-63-0 | 雷帕霉素(西罗莫司)杂质29 | Rapamycin, 9,14-deepoxy-15-deoxo-14-deoxy-9,15-epoxy-15-hydroxy-14-oxo-, (15R)- (9CI) | C51H79NO13
| | |
| 9 | 147438-29-7 | 依维莫司杂质 DCP | 2-Piperidinecarboxylic acid, 1-[[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrienyl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]oxoacetyl]-, (1S,4R,5E)-1-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-4,6-dimethyl-3,7-dioxo-5-heptenyl es... | C51H79NO13
| | |
| 10 | 151945-42-5 | Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- | Pyrido[2,1-c][1,4]oxazine-1,4(3H,6H)-dione, tetrahydro-3-hydroxy-3-[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]-, [2R-[2α,2(3R*,9aS*),3α,6β[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]- | C51H79NO13
| | |